Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry.
Marta Araujo-CastroMiguel Paja FanoMarga González BoillosBegoña Pla PerisEider Pascual-CorralesAna María García CanoPaola Parra RamírezPatricia Martín Rojas-MarcosJorge Gabriel Ruiz-SanchezAlmudena Vicente DelgadoEmilia Gómez HoyosRui FerreiraIñigo García SanzPatricia Díaz GuardiolaJuan Jesús García GonzálezCarolina M PerdomoManuel MoralesFelicia A HanzuPublished in: Endocrine (2022)
In patients with PA, MRA and surgery offer a similar short-term cardiovascular protection, but surgery improves biochemical control and reduces pill burden more commonly than MRA, and lead to hypertension cure or improvement in up to 83% of the patients.